/
Company Overview Aytu BioPharma, Inc. ( Aytu, the Company, we, us, or our ) is a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients. We were originally incorporated as Rosewind Corporation on August 9, 2002, in the state of Colorado and re-incorporated as Aytu BioScience, Inc. in the state of D…
The business is unprofitable at the operating level (-11.79% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue growth slowed to 1.8%, essentially flat. Margins also contracted 9.4pp. This is a business that needs a catalyst.
ROIC dropped from -2.46% to -16.07%, capital efficiency is deteriorating. Negative free cash flow of -$2M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (TTM)
$57M
▲ +1.8% YoY
Net Income (TTM)
-$34M
▲ +14.4% YoY
Op. Margin
-26.79%
▼ -9.4pp YoY
ROIC
-33.17%
▼ -13.6pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$2M
▼ -26.1% YoY
Op. Cash Flow (TTM)
$2M
▼ -39.6% YoY
Net Debt
-$14M
Net Cash Position
Cash & Equiv.
$27M
5Y CAGR: +19.2%
Continue Research